26 Feb 2017 - 1:04pm

Call us: +44 (0) 207 754 0050

Press Releases in Pharmaceuticals

Cavion to Present Clinical Trial Preliminary Results at ASTRO

[PRESSWIRE] CHARLOTTESVILLE, Va. - 26 September, 2016 -- Cavion LLC, a pharmaceutical company developing T-type calcium channel (Cav3) inhibitors for the treatment of oncologic and neurologic diseases, announced today that Ranjit Bindra, MD, PhD and Nataniel Lester-Coll, MD will present preliminary results from an ongoing Yale University Cancer Center and Cavion-sponsored Phase 1 clinical trial at the Annual Meeting of the American Society for Therapeutic Radiation and Oncology (ASTRO) being held in Boston, Massachusetts, September 25-28.

AOR’s NEW RED YEAST RICE FORMULA RYR ANKASCIN -568-R™ OFFERS THE CARDIOVASCULAR HEALTH BENEFITS OF STATINS BUT WITHOUT THE SIDE EFFECTS

[PRESSWIRE] Calgary, Alberta, Canada - September 20, 2016 -- Developed by AOR, RYR Ankascin -568-R™ is the Only Patented, Clinically Studied, Regulatory Compliant, and Commercially Available Red Yeast Rice Extract Free of Monacolin K.

Scibase Passes Milestone – Nevisense Now Available at 100 Clinics in Germany

[PRESSWIRE] STOCKHOLM - 08 July, 2016 -- Regulatory News: The interest in and acceptance of SciBase’s method for early detection of malignant melanoma is increasing, which is demonstrated by the fact that the 100th clinic in Germany installed SciBase’s device Nevisense in June. Sales of electrodes; an effect of the adoption of Nevisense, are steadily increasing and rose by 208 percent in Germany during 2015.

Pages

Subscribe to Press Releases in Pharmaceuticals